BioVaxys Secures GMP-Grade Lipid Supply for Production of DPX-Based Vaccines
December 17, 2024
BioVaxys Technology Corp is pleased to announce that in anticipation of restarting clinical studies of various DPX formulations and initiating new preclinical studies, it has